A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and claims of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.
Some experts said the demand for retatrutide could be connected to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or prison.
Platform Response and Content Removal
Based on TikTok, the service has taken down problematic material and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home.
Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Within these groups, posts show dark colored packages with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously seen individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious health risks”.
